Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) Stock Information | RedChip
Image

ASK REDCHAT® ANYTHING ABOUT KINIKSA PHARMACEUTICALS, LTD.

Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA)
Listen to this Section


$19.42
+0.6760 ( +3.28% ) 181.1K

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

Market Data


Open $19.42
Previous Close $18.74
Volume 181.1K
Market Cap $1.35B
Day Range $18.25 - $19.84
52 Week Range $16.56 - $28.15
Shares Outstanding 72.20M
Change % +3.28%
Net Change ▲ 0.6760
Insider Ownership -0.02%
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
IPO Year 2018
Country United States
Under Writer IPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -449,791.00

Date Type Amount Purchased Purchaser
2024-07-25 Sale -136124.00 Patel Sanj K
2024-07-25 Sale -22000.00 Paolini John F.
2024-07-25 Sale -24248.00 Ragosa Mark
2024-06-07 Sale -6346.00 BAKER BROS. ADVISORS LP
2024-06-07 Sale -4373.00 Levy Richard S
2024-06-07 Sale -4373.00 McCain Tracey L
2024-06-07 Sale -4373.00 Malley Thomas
2024-06-07 Sale -4373.00 Cole G Bradley
2024-06-07 Sale -4373.00 Quart Barry D
2024-06-07 Sale -4373.00 Popovits Kimberly J

Institutional Ownership

Total Market Value $ 0.00

Symbol Issuer Name Market Value ↓ Share Quantity
No records found.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 15 Mar 29, 2024
4 Insider transactions 1 Mar 11, 2024
4 Insider transactions 1 Mar 06, 2024
4 Insider transactions 1 Mar 05, 2024
4 Insider transactions 1 Mar 05, 2024
4 Insider transactions 1 Mar 01, 2024
4 Insider transactions 1 Feb 29, 2024
10-k Annual reports 98 Feb 28, 2024
8-k 8K-related 16 Feb 28, 2024

Latest News


× Before browsing our site, please accept our cookies policy